Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 532 (ZNF532) is a nuclear protein predicted to function as a transcription factor, and is involved in the regulation of gene transcription by DNA binding[4][5][7]. It belongs to the large family of C2H2-type zinc finger proteins, which are characterized by their ability to bind DNA via zinc ion-stabilized finger-like motifs and thus regulate various transcriptional programs[3][5]. ZNF532 has been annotated as a regulator of DNA-templated transcription primarily through nucleic acid binding and is predominantly localized to the cell nucleus[4][5][7]. While many zinc finger proteins have established roles in genome stability and cancer, the specific biological and disease functions of ZNF532 remain incompletely characterized, though associations have been reported with certain cancers and inflammatory disorders[5][7]. No approved drugs directly target ZNF532, and there is no established biomarker or mechanism of action for potential therapeutics at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 532 (ZNF532).